公开(公告)号：US20090203731A1

公开(公告)日：2009-08-13

申请号：US12389764

申请日：2009-02-20

Applicant: Connie Sanchez ,  Bjarke Ebert

Inventor： Connie Sanchez ,  Bjarke Ebert

IPC: A61K31/437 ,  A61P25/00

CPC classification number: A61K31/4745

Abstract: The present invention relates to use of gaboxadol for preparing a pharmaceutical composition for treating depression. Moreover, it relates to the use of gaboxadol for the preparation of a pharmaceutical composition to be used in combination with a serotonin reuptake inhibitor, or any other compound which causes an elevation in the level of extracellular serotonin.

Abstract translation: 本发明涉及加波沙朵用于制备治疗抑郁症的药物组合物的用途。 此外，它涉及使用加波沙朵来制备与5-羟色胺再摄取抑制剂或任何其它引起细胞外5-羟色胺水平升高的化合物组合使用的药物组合物。

公开(公告)号：US20050234093A1

公开(公告)日：2005-10-20

申请号：US11020632

申请日：2004-12-22

Applicant: Connie Sanchez ,  Bjarke Ebert

Inventor： Connie Sanchez ,  Bjarke Ebert

IPC: A61K31/4745

CPC classification number: A61K31/4745

Abstract: The present invention relates to use of gaboxadol for preparing a pharmaceutical composition for treating depression. Moreover, it relates to the use of gaboxadol for the preparation of a pharmaceutical composition to be used in combination with a serotonin reuptake inhibitor, or any other compound which causes an elevation in the level of extracellular serotonin.

Abstract translation: 本发明涉及加波沙朵用于制备治疗抑郁症的药物组合物的用途。 此外，它涉及使用加波沙朵来制备与5-羟色胺再摄取抑制剂或任何其它引起细胞外5-羟色胺水平升高的化合物组合使用的药物组合物。

公开(公告)号：US20050288371A1

公开(公告)日：2005-12-29

申请号：US11020630

申请日：2004-12-22

Applicant: Bjarke Ebert ,  Connie Sanchez

Inventor： Bjarke Ebert ,  Connie Sanchez

IPC: A61K31/195

CPC classification number: A61K31/195 ,  A61K31/437 ,  Y02A50/401

Abstract: The present invention relates to the use of gaboxadol for the preparation of medicaments useful for the treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis.

Abstract translation: 本发明涉及加波沙朵用于制备可用于治疗神经性疼痛，纤维肌痛或类风湿性关节炎的药物的用途。

公开(公告)号：US20050101665A1

公开(公告)日：2005-05-12

申请号：US10644143

申请日：2003-08-20

Applicant: Connie Sanchez ,  Sandra Hogg

Inventor： Connie Sanchez ,  Sandra Hogg

IPC: C07D307/87 ,  A61K31/343 ,  A61K31/352 ,  A61P25/00 ,  A61P25/20 ,  A61P25/22

CPC classification number: A61K31/343 ,  Y10S514/962

Abstract: Use of escitalopram (the S-(+)-enantiomer of citalopram) or a pharmaceutically acceptable salt thereof for the preparation of a medicament useful in the treatment of neurotic disorders is provided, including anxiety states, in particular generalised anxiety disorder and social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder and panic attacks.

Abstract translation: 提供了依他普仑（西酞普兰的S-（+） - 对映异构体）或其药学上可接受的盐在制备用于治疗神经性疾病的药物中的应用，包括焦虑状态，特别是广泛性焦虑症和社会焦虑症 ，创伤后应激障碍，强迫症和恐慌发作。

公开(公告)号：US20080004338A1

公开(公告)日：2008-01-03

申请号：US11853949

申请日：2007-09-12

Applicant: Connie Sanchez ,  Jesper Lyng Jensen ,  Arne Mork

Inventor： Connie Sanchez ,  Jesper Lyng Jensen ,  Arne Mork

IPC: A61K31/343 ,  A61P25/24

CPC classification number: A61K31/343

Abstract: The present invention relates to the use of anantiomeric pure escitalopram and/or of low dose medicaments thereof for the improved treatment of depression, in particular major depression disorder, neurotic disorders, acute stress disorder, eating disorders such as bulimia, anorexia and obesity, phobias, dysthymia, pre-menstrual syndrome, cognitive disorders, impulse control disorders, attention deficit hyperactivity disorder or drug abuse. The medicaments may also be used in the treatment of major depression disorder in “treatment resistant” patients.

Abstract translation: 本发明涉及对映体纯的依他普仑和/或其低剂量药物用于改善治疗抑郁症，特别是重症抑郁障碍，神经性疾病，急性应激障碍，进食障碍如贪食症，厌食症和肥胖症，恐惧症 ，精神郁闷，月经前综合征，认知障碍，冲动控制障碍，注意缺陷多动障碍或药物滥用。 药物也可用于治疗“治疗耐药”患者的重症抑郁障碍。

公开(公告)号：US06960613B2

公开(公告)日：2005-11-01

申请号：US10644143

申请日：2003-08-20

Applicant: Connie Sanchez ,  Sandra Hogg

Inventor： Connie Sanchez ,  Sandra Hogg

IPC: C07D307/87 ,  A61K31/343 ,  A61K31/352 ,  A61P25/00 ,  A61P25/20 ,  A61P25/22 ,  A61K31/34

CPC classification number: A61K31/343 ,  Y10S514/962

Abstract: Use of escitalopram (the S-(+)-enantiomer of citalopram) or a pharmaceutically acceptable salt thereof for the preparation of a medicament useful in the treatment of neurotic disorders is provided, including anxiety states, in particular generalised anxiety disorder and social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder and panic attacks.

公开(公告)号：US07271194B2

公开(公告)日：2007-09-18

申请号：US10021126

申请日：2001-12-12

Applicant: Connie Sanchez ,  Sandra Hogg

Inventor： Connie Sanchez ,  Sandra Hogg

IPC: A61K31/34 ,  A61K31/335

CPC classification number: A61K31/343 ,  Y10S514/962

Abstract: Use of escitalopram (the S-(+)-enantiomer of citalopram) or a pharmaceutically acceptable salt thereof for the preparation of a medicament useful in the treatment of neurotic disorders is provided, including anxiety states, in particular generalised anxiety disorder and social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder and panic attacks.

公开(公告)号：US07265151B2

公开(公告)日：2007-09-04

申请号：US10637820

申请日：2003-08-07

Applicant: Connie Sanchez ,  Sandra Hogg

Inventor： Connie Sanchez ,  Sandra Hogg

IPC: A16K31/34

CPC classification number: A61K31/343 ,  Y10S514/962

Abstract: Use of escitalopram (the S-(+)-enantiomer of citalopram) or a pharmaceutically acceptable salt thereof for the preparation of a medicament useful in the treatment of neurotic disorders is provided, including anxiety states, in particular generalised anxiety disorder and social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder and panic attacks.

Abstract translation: 提供了依他普仑（西酞普兰的S-（+） - 对映异构体）或其药学上可接受的盐在制备用于治疗神经性疾病的药物中的应用，包括焦虑状态，特别是广泛性焦虑症和社会焦虑症 ，创伤后应激障碍，强迫症和恐慌发作。

公开(公告)号：US20050101666A1

公开(公告)日：2005-05-12

申请号：US10984536

申请日：2004-11-08

Applicant: Connie Sanchez

Inventor： Connie Sanchez

IPC: A61K31/343

CPC classification number: A61K31/343

Abstract: The present invention relates to a method of treating the symptoms of premenstrual dysphoric disorder (PMDD) in a patient in need thereof by administering an effective amount of escitalopram or a pharmaceutically acceptable salt thereof.

Abstract translation: 本发明涉及通过施用有效量的依他普仑或其药学上可接受的盐来治疗有需要的患者中经前焦虑症（PMDD）的症状的方法。

公开(公告)号：US20070276035A1

公开(公告)日：2007-11-29

申请号：US11837317

申请日：2007-08-10

Applicant: Connie Sanchez ,  Sandra Hogg

Inventor： Connie Sanchez ,  Sandra Hogg

IPC: A61K31/343 ,  A61P25/24 ,  A61K9/48

CPC classification number: A61K31/343 ,  Y10S514/962

Abstract: Use of escitalopram (the S-(+)-enantiomer of citalopram) or a pharmaceutically acceptable salt thereof for the preparation of a medicament useful in the treatment of neurotic disorders is provided, including anxiety states, in particular generalized anxiety disorder and social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder and panic attacks.

Abstract translation: 提供了依他普仑（西酞普兰的S-（+） - 对映异构体）或其药学上可接受的盐在制备用于治疗神经性疾病的药物中的应用，包括焦虑状态，特别是广泛性焦虑症和社会焦虑症 ，创伤后应激障碍，强迫症和恐慌发作。